MA26749A1 - Composition d'ovule vaginal a la clindamycine - Google Patents

Composition d'ovule vaginal a la clindamycine

Info

Publication number
MA26749A1
MA26749A1 MA26034A MA26034A MA26749A1 MA 26749 A1 MA26749 A1 MA 26749A1 MA 26034 A MA26034 A MA 26034A MA 26034 A MA26034 A MA 26034A MA 26749 A1 MA26749 A1 MA 26749A1
Authority
MA
Morocco
Prior art keywords
clindamycin
composition
vaginal
vaginal ovule
company
Prior art date
Application number
MA26034A
Other languages
English (en)
Inventor
Lorraine E Pena
Carolyn V Pesheck
Robert S Chao
Phil B Bowman
Original Assignee
Pharmacia & Upjohn Company Eta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Company Eta filed Critical Pharmacia & Upjohn Company Eta
Publication of MA26749A1 publication Critical patent/MA26749A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

DEPOSANT Société dite: PHARMACIA & UPJOHN COMPANY REVENDICATION DE PRIORITES US 06/08/1999 60/147,561 Voir en annexe le titre de l'invention et le texte de l'abrégé "Composition d'ovule vaginal à la clindamycine" L'invention consiste en une composition, extrêmement stable à l'entreposage, d'ovules pour l'administration vaginale de clindamycine. Cette composition contient une quantité efficace du point de vue antimicrobien de clindamycine dispersée dans un excipient consistant en graisse dure NF. Application : utilisation de ces ovules pour le traitement des vaginites bactériennes, avec une efficacité équivalente à celle des crèmes vaginales à la clindamycine.
MA26034A 1999-08-06 2000-08-04 Composition d'ovule vaginal a la clindamycine MA26749A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14756199P 1999-08-06 1999-08-06

Publications (1)

Publication Number Publication Date
MA26749A1 true MA26749A1 (fr) 2004-12-20

Family

ID=22522061

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26034A MA26749A1 (fr) 1999-08-06 2000-08-04 Composition d'ovule vaginal a la clindamycine

Country Status (24)

Country Link
US (2) US6495157B1 (fr)
EP (1) EP1200065B1 (fr)
JP (1) JP2003519095A (fr)
KR (1) KR100670085B1 (fr)
CN (1) CN1160056C (fr)
AR (1) AR025045A1 (fr)
AT (1) ATE250408T1 (fr)
AU (1) AU768907B2 (fr)
CA (1) CA2378572A1 (fr)
DE (1) DE60005524T2 (fr)
DK (1) DK1200065T3 (fr)
ES (1) ES2207532T3 (fr)
HK (1) HK1047538A1 (fr)
HN (1) HN2000000166A (fr)
MA (1) MA26749A1 (fr)
MX (1) MXPA02001320A (fr)
NZ (1) NZ517039A (fr)
PA (1) PA8499101A1 (fr)
PE (1) PE20010484A1 (fr)
PT (1) PT1200065E (fr)
SI (1) SI1200065T1 (fr)
SV (1) SV2001000138A (fr)
TW (1) TWI232111B (fr)
WO (1) WO2001010407A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
AU2002238063A1 (en) * 2002-02-05 2004-02-25 Pharmacia And Upjohn Company Composition and method for rectal delivery of a lincosamide antibacterial drug
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
EP1648418A4 (fr) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc Produit antibiotique, utilisation et formulation associees
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2533292C (fr) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Produit antibiotique, utilisation et formulation correspondantes
CA2535177A1 (fr) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Pastille robuste
EP1653924A4 (fr) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In Antibiotique, utilisation et formulation associees
CA2535780A1 (fr) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Produit antibiotique, son utilisation et sa formulation
US8460710B2 (en) 2003-09-15 2013-06-11 Shionogi, Inc. Antibiotic product, use and formulation thereof
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US20050095245A1 (en) * 2003-09-19 2005-05-05 Riley Thomas C. Pharmaceutical delivery system
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
US20070065504A1 (en) * 2004-03-23 2007-03-22 Lin Shun Y Products and methods for treating vaginal infections
CA2572292A1 (fr) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Comprime pour distribution par impulsion
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20060078616A1 (en) * 2004-08-30 2006-04-13 Georgewill Dawaye A Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol
MX2007013631A (es) * 2005-05-09 2008-01-24 Drugtech Corp Composiciones farmaceuticas de liberacion modificada.
CN100446774C (zh) * 2005-05-31 2008-12-31 黑龙江龙桂制药有限公司 盐酸克林霉素阴道泡腾片及其制备方法
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
JP2009522360A (ja) * 2006-01-05 2009-06-11 ドラッグテック コーポレイション 組成物およびその使用方法
EP1968544A2 (fr) * 2006-01-05 2008-09-17 Drugtech Corporation Systeme de liberation de medicament bioadherent a la surface vulvovaginale
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
DE102009055644A1 (de) * 2009-11-25 2011-06-01 Nicole Nedela Dildo-Set
CN103735491B (zh) * 2013-12-31 2016-01-13 哈尔滨欧替药业有限公司 克林霉素磷酸酯阴道膨胀栓及其制备方法和检测方法
US10813963B2 (en) 2018-09-04 2020-10-27 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
US10695301B2 (en) 2018-09-04 2020-06-30 Babak Ghalili Veterinary cannabinoid and menthol compositions and methods
WO2021177938A1 (fr) * 2020-03-02 2021-09-10 Babak Ghalili Compositions vétérinaires à base de cannabinoïdes et de menthol et procédés associés
MX2020011523A (es) * 2020-10-29 2022-05-02 Exeltis Pharma Mexico S A De C V Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2812683B2 (ja) * 1988-07-26 1998-10-22 富士製薬工業株式会社 持続性を有するモルヒネ直腸投与製剤
JPH05213752A (ja) * 1992-02-06 1993-08-24 Fujisawa Asutora Kk 坐 剤
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
DE19737348C2 (de) * 1997-08-27 2002-07-25 Dan-Gabriel Vulpescu Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition

Also Published As

Publication number Publication date
AU6219800A (en) 2001-03-05
HK1047538A1 (en) 2003-02-28
TWI232111B (en) 2005-05-11
AU768907B2 (en) 2004-01-08
KR20020038713A (ko) 2002-05-23
US20020197320A1 (en) 2002-12-26
PA8499101A1 (es) 2001-12-14
NZ517039A (en) 2003-01-31
JP2003519095A (ja) 2003-06-17
AR025045A1 (es) 2002-11-06
KR100670085B1 (ko) 2007-01-17
HN2000000166A (es) 2001-04-20
ES2207532T3 (es) 2004-06-01
DE60005524D1 (de) 2003-10-30
CA2378572A1 (fr) 2001-02-15
WO2001010407A1 (fr) 2001-02-15
MXPA02001320A (es) 2004-09-10
SV2001000138A (es) 2001-10-24
PT1200065E (pt) 2004-02-27
DK1200065T3 (da) 2004-02-02
EP1200065B1 (fr) 2003-09-24
US6495157B1 (en) 2002-12-17
ATE250408T1 (de) 2003-10-15
EP1200065A1 (fr) 2002-05-02
SI1200065T1 (en) 2004-04-30
PE20010484A1 (es) 2001-04-20
DE60005524T2 (de) 2004-08-05
CN1160056C (zh) 2004-08-04
CN1360495A (zh) 2002-07-24

Similar Documents

Publication Publication Date Title
MA26749A1 (fr) Composition d'ovule vaginal a la clindamycine
BRPI0615265A8 (pt) composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos
ATE491436T1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
MX2008011085A (es) Composiciones antimicrobianas y metodos para sellar cateteres.
MA31675B1 (fr) Petites molecules contenant du bore
WO2006103037A3 (fr) Composition contenant la $g(b)-defensine 2
AR024874A1 (es) Composiciones bactericidas
DZ3167A1 (fr) Combinaison de bactéries d'acide lactique et son utilisation pour prevenir et/ou traiter les infections et les états inflammatoires.
FR2887450B1 (fr) Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques
TNSN06205A1 (fr) Utilisation d'un lyophilisat de cellules végétales dédifférenciées afin de dépigmenter et/ou d'éclaircir la peau
RU2012133314A (ru) Борьба с эктопаразитами
HUP0004905A2 (hu) Biocid készítmények
BR9903415A (pt) Composição para exterminação de artrópodes nocivos
FR2891460B1 (fr) Utilisation d'au moins un compose de la famille des avermectines pour le traitement des pathologies ophtalmiques dues au demodex folliculorum.
MA29485B1 (fr) Motilides
CA2216569A1 (fr) Utilisation de derives d'oxazolidinone comme agents anti-penetrants dans une composition cosmetique et/ou dermatologique
FR2885491B1 (fr) Traitement de la secheresse keratinique par des glycerides
CL2004001012A1 (es) Compuestos derivados de macrolidos de 14 o 15 miembros, sustituidos en posicion 4"; procedimiento para su preparacion; composicion farmaceutica que lo comprende; y su uso para el tratamiento o profilaxis de infecciones microbianas sistemicas o topica
MA26896A1 (fr) Utilisation de compositions d'antibiotiques azalides pour le traitement ou la prevention d'une infection par des bacteries ou protozoaires chez des mammiferes
ATE417915T1 (de) Reinigungsaktive und desinfizierende zusammensetzung
FR2919187B1 (fr) Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
RU2006107864A (ru) Средство "вагитрит" антимикробного действия
FR2811895B1 (fr) Composition de traitement cosmetique comprenant au moins un betainate d'amidon specifique et au moins un tensioactif detergent, procede de traitement cosmetique des matieres keratiniques et utilisation de la composition
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
FR2907682B1 (fr) Composition cosmetique et/ou pharmaceutique comprenant comme principe actif au moins un peptide et utilisation de ce peptide.